Skip to content

BioDelivery Sciences International, Inc.: 10-Q filed 2014-08-07

What BioDelivery Sciences International, Inc. reported in its quarterly report filed 2014-08-07 (fiscal Q2 2014): 37 published measures, 95 facts as tagged in accession 0001193125-14-300803.

This filing

Form
10-Q (quarterly report)
Filed
2014-08-07
Fiscal period
fiscal Q2 2014
Accession
0001193125-14-300803 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioDelivery Sciences International, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-30103,841,041USD
At 2013-12-3138,005,425USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-3042,044,543USD
At 2013-12-3138,817,776USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-3061,796,498USD
At 2013-12-31-812,351USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-06-3078,364,276USD
At 2013-12-3123,175,809USD
At 2013-06-3037,430,878USD
At 2012-12-3163,189,307USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-11,315,780USD181
2013-01-01 to 2013-06-30-26,137,651USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-06-301,020,237USD181
2013-01-01 to 2013-06-301,648USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-04-01 to 2014-06-3013,884,577USD91
2014-01-01 to 2014-06-3034,574,379USD181
2013-04-01 to 2013-06-302,764,050USD91
2013-01-01 to 2013-06-304,386,027USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-06-3064,946,100USD181
2013-01-01 to 2013-06-309,235USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-06-30-162,628,788USD
At 2013-12-31-151,313,008USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-04-01 to 2014-06-3048,521,351shares91
2014-01-01 to 2014-06-3046,290,712shares181
2013-04-01 to 2013-06-3037,998,610shares91
2013-01-01 to 2013-06-3037,756,309shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-0.14USD/shares91
2014-01-01 to 2014-06-30-0.24USD/shares181
2013-04-01 to 2013-06-30-0.35USD/shares91
2013-01-01 to 2013-06-30-0.69USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-0.14USD/shares91
2014-01-01 to 2014-06-30-0.24USD/shares181
2013-04-01 to 2013-06-30-0.35USD/shares91
2013-01-01 to 2013-06-30-0.69USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-06-3085,000USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-06-30237,908USD
At 2013-12-31178,168USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-06-302,479,256USD181
2013-01-01 to 2013-06-301,365,259USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-2,041,325USD91
2014-01-01 to 2014-06-30-1,328,365USD181
2013-04-01 to 2013-06-30-13,808,126USD91
2013-01-01 to 2013-06-30-27,520,073USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-3092,400,197USD
At 2013-12-3126,600,506USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-3028,894,555USD
At 2013-12-3124,991,585USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-06-302,715,000USD
At 2013-12-312,715,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-06-3012,639,549USD
At 2013-12-312,794,040USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-04-01 to 2014-06-3015,238,936USD91
2014-01-01 to 2014-06-3034,490,181USD181
2013-04-01 to 2013-06-3015,881,969USD91
2013-01-01 to 2013-06-3030,840,893USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-06-30795,374USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-04-01 to 2014-06-30686,966USD91
2014-01-01 to 2014-06-301,412,563USD181
2013-04-01 to 2013-06-30690,207USD91
2013-01-01 to 2013-06-301,065,207USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-04-01 to 2014-06-307,982,976USD91
2014-01-01 to 2014-06-3022,606,197USD181
2013-04-01 to 2013-06-3012,758,215USD91
2013-01-01 to 2013-06-3024,790,383USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-3049,110,386shares
At 2013-12-3138,188,893shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-06-30224,421,204USD
At 2013-12-31150,506,927USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-06-304,711,320USD
At 2013-12-315,196,498USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-30313,690USD
At 2013-12-31470,535USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-30700,000USD
At 2013-12-31700,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-06-30600,998USD
At 2013-12-31630,657USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-6,671,369USD91
2014-01-01 to 2014-06-30-11,315,780USD181
2013-04-01 to 2013-06-30-13,415,011USD91
2013-01-01 to 2013-06-30-26,137,651USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-307,249,960USD91
2014-01-01 to 2014-06-3011,871,984USD181
2013-04-01 to 2013-06-303,110,754USD91
2013-01-01 to 2013-06-306,021,010USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-06-30509,741USD181
2013-01-01 to 2013-06-30685,759USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-04-01 to 2014-06-309,053USD91
2014-01-01 to 2014-06-3032,385USD181
2013-04-01 to 2013-06-30-95,477USD91
2013-01-01 to 2013-06-30-118,631USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-06-303,900,000USD181
2014-01-01 to 2014-01-313,900,000USD31

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-309,845,509USD181
2013-01-01 to 2013-06-30-11,796USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30795,374USD181

Inspect the source

Entity
BioDelivery Sciences International, Inc. / CIK 0001103021
Captured
SEC response SHA-256
75706c640f98d31c5d9173e000d4bb8a3beba531484b5fc6395a3a842bd4ad19

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001103021.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))